These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 1706856)
1. Prophylactic use of implantable cardioverter defibrillators: medical, technical, economic considerations. Bigger JT Pacing Clin Electrophysiol; 1991 Feb; 14(2 Pt 2):376-80. PubMed ID: 1706856 [No Abstract] [Full Text] [Related]
2. Identifying patients for prophylactic automatic implantable cardioverter defibrillator therapy: status of prospective studies. Nisam S; Thomas A; Mower M; Hauser R Am Heart J; 1991 Aug; 122(2):607-12. PubMed ID: 1858656 [No Abstract] [Full Text] [Related]
3. Early automatic implantable cardioverter-defibrillator implantation: medical and economic considerations and inequities in health care reimbursement. Winkle RA J Am Coll Cardiol; 1990 Nov; 16(5):1264-6. PubMed ID: 2121812 [No Abstract] [Full Text] [Related]
5. Evaluation of the implantable cardioverter defibrillator in survivors of cardiac arrest: the need for randomized trials. Connolly SJ; Yusuf S Am J Cardiol; 1992 Apr; 69(9):959-62. PubMed ID: 1550027 [No Abstract] [Full Text] [Related]
7. Implantable defibrillators for prevention of sudden death. Technology at a medical and economic crossroad. Saksena S; Camm AJ Circulation; 1992 Jun; 85(6):2316-21. PubMed ID: 1591847 [TBL] [Abstract][Full Text] [Related]
8. Implantable cardioverter defibrillators: where do we go from here? Wyndham CR J Am Coll Cardiol; 1992 Mar; 19(4):789-91. PubMed ID: 1545075 [No Abstract] [Full Text] [Related]
9. The wearable cardioverter-defibrillator: current technology and evolving indications. Reek S; Burri H; Roberts PR; Perings C; Epstein AE; Klein HU; ; Lip G; Gorenek B; Sticherling C; Fauchier L; Goette A; Jung W; Vos MA; Brignole M; Elsner C; Dan GA; Marin F; Boriani G; Lane D; Blomström-Lundqvist C; Savelieva I Europace; 2017 Mar; 19(3):335-345. PubMed ID: 27702851 [TBL] [Abstract][Full Text] [Related]
11. Role of the automatic implantable cardioverter defibrillator in the prevention of sudden cardiac death. Capucci A; Boriani G Int J Artif Organs; 1992 Jan; 15(1):1-4. PubMed ID: 1551722 [No Abstract] [Full Text] [Related]
12. Cost-effectiveness considerations: the Dutch prospective study of the automatic implantable cardioverter defibrillator as first-choice therapy. Wever EF; Hauer RN Pacing Clin Electrophysiol; 1992 Apr; 15(4 Pt 3):690-3. PubMed ID: 1375372 [No Abstract] [Full Text] [Related]
13. Are the benefits of the automatic implantable cardioverter-defibrillator (AICD) overestimated by sudden death rate? Henthorn RW; Waller TJ; Hiratzka LF J Am Coll Cardiol; 1991 Jun; 17(7):1593-4. PubMed ID: 2033192 [No Abstract] [Full Text] [Related]
14. Life after sudden death: the development of a support group for automatic implantable cardioverter-defibrillator patients. Teplitz L; Egenes KJ; Brask L J Cardiovasc Nurs; 1990 Feb; 4(2):20-32. PubMed ID: 2366064 [TBL] [Abstract][Full Text] [Related]
15. Wearable cardioverter-defibrillator as a bridge to implantable cardioverter-defibrillator treatment. Technol Eval Cent Assess Program Exec Summ; 2010 Nov; 25(2):1-5. PubMed ID: 21638938 [No Abstract] [Full Text] [Related]